110,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Gebundenes Buch

Microbiome in Neurological Disease, Volume 167 in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Section in this new release cover Intersections of the microbiome and early neurodevelopment, Microbiome influences on neuro-immune interactions, The genomes of Parkinson's disease, Experimental contributions of the microbiome to Parkinson's disease, The foundations of microbiome contributions to Alzheimer's disease, Immunologic pathways by which the gut…mehr

Produktbeschreibung
Microbiome in Neurological Disease, Volume 167 in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Section in this new release cover Intersections of the microbiome and early neurodevelopment, Microbiome influences on neuro-immune interactions, The genomes of Parkinson's disease, Experimental contributions of the microbiome to Parkinson's disease, The foundations of microbiome contributions to Alzheimer's disease, Immunologic pathways by which the gut microbiota influences Alzheimer's disease, Role of the gut microbiome in Huntington's Disease, and much more.
Autorenporträt
Dr. Sampson's primary research interests lie in understanding how the complex interactions between indigenous microbes and the host can shape neurological responses, during neurodegenerative disease and neurological injury. His academic career to date has uniquely positioned him with training across broad topics: microbiology, immunology, genetics, molecular biology, and biochemistry. Following postdoctoral studies at Caltech, with Dr. Sarkis Mazmanian, he utilized his background in bacterial genetics and host-pathogen interactions to explore how indigenous microbes influence Parkinson's disease (PD). These activities have laid the foundation for his independent career exploring host-microbe interactions at the interface of PD, Alzheimer's disease (AD) and other neurological illnesses--diseases historically studied within the context of the central nervous system.